Biotech & Pharma.T.A, Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A,

BIB 83.86

+1.3%

Dec 24 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Ian@SI who wrote (1754)	1/25/2008 10:58:14 PM
From: Jibacoa	Read Replies (1) of 3722

AMGN opened with an UG & was up 4.38% on volume of 24,854,415 > 2x its ADV, it closed above $48 & continued to do OK AHs. bigcharts.marketwatch.com It announced yesterday after the market closed, the results of a double-blind study comparing denosumab given by subcutaneous injections 2x Yr. vs. oral doses of FOSAMAX given 1x week, on bone density in postmenopausal women.It said that the study met its primary & all its secondary endpoints. The drug showed greater bone density gains at the hip & distal radius than Fosamax.The primary endpoint was the magnitude of bone density improvement at the hip, which was approximately 40% greater than in the Fosamax group. The incidence of side effects were similar in both groups, which involved a total of 1,189 women with postmenopausal osteoporosis. Analyst have a target for AMGN around $60 but the stock still needs to close its Dec10 DG. bigcharts.marketwatch.com AMGB Trades around 2.65xBV with a +CF around $4.80 It has had better earnings in its last 4Qs in spiet of lower revenues in the last 2Qs. The EE for 2008 are for further improvement to around $4.40/shr & for 2009 to around $4.80/shr The short ratio came down almost 20% in the last month & still is around 2x its ADV. If it can close its Dec 10 DG, it seems the stock should be able to test the resistance from its June-Oct H at the 59 level. bigcharts.marketwatch.com On a close above $60, the stock will start getting off from its long term DT coming from its Sep 2005 at the $86.92 level bigcharts.marketwatch.com Bernard

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next